Certified by Founder Lodge
Cross-Border Impact Ventures
Canada - Toronto, Ontario
INVESTOR
1 Disclosed Funding Rounds $11,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cross Border Impact Ventures aims to be the preferred investor for transformative health technology companies with the potential of meeting the needs of women, children and adolescents across
Company | Date | Round | Raised |
---|---|---|---|
Daye | October, 26 ,2022 | Series A | $11,500,000 |
OncoLens | July, 17 ,2023 | Unknown | |
Raydiant Oximetry, Inc. | June, 05 ,2024 | Series A | $7,500,000 |
Oxford Cancer Analytics | January, 10 ,2025 | Series A | $11,000,000 |